RPG Investment Advisory’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-125
| Closed | -$23K | – | 365 |
|
|
2021
Q2 | $23K | Hold |
125
| – | – | ﹤0.01% | 169 |
|
|
2021
Q1 | $19K | Hold |
125
| – | – | ﹤0.01% | 177 |
|
|
2020
Q4 | $20K | Hold |
125
| – | – | ﹤0.01% | 164 |
|
|
2020
Q3 | $14K | Hold |
125
| – | – | ﹤0.01% | 169 |
|
|
2020
Q2 | $14K | Hold |
125
| – | – | ﹤0.01% | 171 |
|
|
2020
Q1 | $11K | Hold |
125
| – | – | ﹤0.01% | 168 |
|
|
2019
Q4 | $14K | Hold |
125
| – | – | ﹤0.01% | 164 |
|
|
2019
Q3 | $12K | Hold |
125
| – | – | ﹤0.01% | 165 |
|
|
2019
Q2 | $16K | Hold |
125
| – | – | ﹤0.01% | 158 |
|
|
2019
Q1 | $17K | Hold |
125
| – | – | ﹤0.01% | 168 |
|
|
2018
Q4 | $12K | Hold |
125
| – | – | ﹤0.01% | 178 |
|
|
2018
Q3 | $17K | Hold |
125
| – | – | ﹤0.01% | 177 |
|
|
2018
Q2 | $16K | Hold |
125
| – | – | ﹤0.01% | 187 |
|
|
2018
Q1 | $14K | Sell |
125
-5,222
| -98% | -$585K | ﹤0.01% | 251 |
|
|
2017
Q4 | $639K | Sell |
5,347
-74
| -1% | -$8.84K | 0.16% | 89 |
|
|
2017
Q3 | $761K | Sell |
5,421
-100
| -2% | -$14K | 0.19% | 82 |
|
|
2017
Q2 | $672K | Buy |
5,521
+217
| +4% | +$26.4K | 0.18% | 86 |
|
|
2017
Q1 | $643K | Sell |
5,304
-341
| -6% | -$41.3K | 0.19% | 88 |
|
|
2016
Q4 | $690K | Sell |
5,645
-200
| -3% | -$24.4K | 0.23% | 79 |
|
|
2016
Q3 | $716K | Sell |
5,845
-200
| -3% | -$24.5K | 0.22% | 82 |
|
|
2016
Q2 | $705K | Buy |
6,045
+505
| +9% | +$58.9K | 0.19% | 88 |
|
|
2016
Q1 | $771K | Sell |
5,540
-165
| -3% | -$23K | 0.3% | 75 |
|
|
2015
Q4 | $1.09M | Buy |
+5,705
| New | +$1.09M | 0.41% | 65 |
|